ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 96
  • Next Page »
Search Again »
  • Abstract Number: 2255 • 2018 ACR/ARHP Annual Meeting

    Increased Cost Burden in an Early Diagnosed Cohort of Uncontrolled Versus Controlled Gout: Analysis of a Large US Payer Database

    Brian LaMoreaux1, Megan Francis-Sedlak2 and Robert J Holt2, 1Horizon Pharma USA, Inc, Lake Forest, IL, 2Horizon Pharma USA, Inc., Lake Forest, IL

    Background/Purpose: Gout is a progressive systemic inflammatory disease that is widely prevalent, estimated to effect 3.9% or 8.3 million people of the United State (US)…
  • Abstract Number: 2352 • 2018 ACR/ARHP Annual Meeting

    Predictors of Patient and Physician Perceptions of Gout Disease Activity

    Nicola Dalbeth1, Christopher Frampton2, Scott Baumgartner3, Maple Fung3 and Hyon K. Choi4, 1University of Auckland, Auckland, New Zealand, 2University of Otago, Christchurch, New Zealand, 3Formerly Ardea Biosciences, San Diego, CA, 4Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA

    Background/Purpose: It is unknown what factors contribute to patient and physician perceptions of gout disease activity, and how these perceptions align.  The aim of this…
  • Abstract Number: 2362 • 2018 ACR/ARHP Annual Meeting

    Understanding Patients’ Perceptions of Gout

    Kelly Gavigan1, Kayla Jordan2, Alexa Meara3 and W. Benjamin Nowell1, 1Global Healthy Living Foundation, Upper Nyack, NY, 2University of Texas at Austin, Austin, TX, 3Internal Medicine/Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH

    Background/Purpose: Past research has shown that patients’ (pts’) knowledge of their disease influences health-related behavior. The objective of this study is to explore gout pts’…
  • Abstract Number: 2962 • 2018 ACR/ARHP Annual Meeting

    Diagnostic Accuracy of Gout in Electronic Health Records and the Role of Rheumatology Electronic Consults

    Juliana Chang1 and Maida Wong2, 1Internal Medicine, University of California, Irvine, School of Medicine, Orange, CA, 2Rheumatology, Tibor Rubin VA Medical Center, Orange, CA

    Background/Purpose: Gout is the most prevalent inflammatory arthritis globally. Despite treatment advances, it still has a significant effect on quality of life and healthcare costs.…
  • Abstract Number: 2964 • 2018 ACR/ARHP Annual Meeting

    Detection of Uric Acid Crystals in the Vasculature of Patients with Gout Using Dual-Energy Computed Tomography

    Sharon Barazani1, WeiWei Chi2, Renata Pyzik3, Adam Jacobi4, Tom O'Donnell5, Zahi Fayad3, Venkatesh Mani3 and Yousaf Ali2, 1Medical School, Icahn School of Medicine at Mount Sinai, New York, NY, 2Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 3Translational and Molecular Imaging Institute (TMII), Icahn School of Medicine at Mount Sinai, New York, NY, 4Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, 5Siemens Healthcare, New York, NY

    Background/Purpose: Many recent studies have shown an association between gout and increased cardiovascular risk, however the mechanism by which this occurs is unclear. Dual-Energy Computed…
  • Abstract Number: 2965 • 2018 ACR/ARHP Annual Meeting

    Targeting Glucose Metabolism in the Murine Air Pouch Model of Acute Gouty Inflammation

    Anyan Cheng1, Roxana Coras1,2, Robert Terkeltaub3,4, Ru Liu-Bryan1,3 and Monica Guma1,2, 1Medicine, University of California San Diego, La Jolla, CA, 2Medicine, Autonomous University of Barcelona, Bellatera, Spain, 3VA San Diego Healthcare System, San Diego, CA, 4Medicine, Division of Rheumatology, Allergy and Immunology. UCSD., La Jolla, CA

    Background/Purpose: Emerging evidence indicates that macrophage activation is critically supported by glucose metabolic shifts. Although macrophages are key contributors to inflammation, little is known about…
  • Abstract Number: 2966 • 2018 ACR/ARHP Annual Meeting

    Ultrasound Shows Rapid Reduction of Uric Load during Treat-to-Target Approach in Gout Patients: Results from a Longitudinal Study

    Hilde B Hammer1, Lars Fritjof Karoliussen2, Lene Terslev3, Espen A. Haavardsholm1, Tore Kvien4 and Till Uhlig5, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 3Rheumatology, Rigshospitalet Glostrup, Copenhagen, Denmark, 4RAID working group for EULAR, Zurich, Switzerland, 5Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose:  Uric monosodium urate (MSU) depositions are detected by ultrasound (US), and US is included in the ACR/EULAR classification criteria for gout. OMERACT definitions for…
  • Abstract Number: 2968 • 2018 ACR/ARHP Annual Meeting

    Role of Choline in Gouty Inflammation

    Elsa Sanchez-Lopez1, Zhenyu Zhong1, Alex Stubelius2, Shannon R Sweeney3, Ru Liu-Bryan4,5, Juan Carlos Lacal6, Stefano Tiziani3,7,8, Robert Terkeltaub4,9, Monica Guma9 and Michael Karin1, 1Department of Pharmacology, School of Medicine. UCSD., La Jolla, CA, 2Division of Rheumatology, Allergy and Immunology. UCSD., La Jolla, CA, 3Department of Nutritional Sciences. The University of Texas at Austin., Austin, TX, 4VA San Diego Healthcare System, San Diego, CA, 5Medicine-Rheumatology, Division of Rheumatology, Allergy and Immunology. UCSD., La Jolla, CA, 6Translational Oncology. Department of Oncology, Hospital Universitario Fuenlabrada, Madrid, Spain, 7Department of Molecular Biosciences, College of Natural Sciences. The University of Texas at Austin., Austin, TX, 8Department of Pediatrics, Dell Medical School. The University of Texas at Austin., Austin, TX, 9Medicine, Division of Rheumatology, Allergy and Immunology. UCSD., La Jolla, CA

    Background/Purpose: Gout is characterized by deposition of monosodium urate (MSU) crystals in articular joints, where they activate macrophages inducing NLRP3 inflammasome activation and bioactive IL-1β…
  • Abstract Number: 2969 • 2018 ACR/ARHP Annual Meeting

    Allopurinol Dose Escalation Slows Progression of CT Bone Erosion in People with Gout: Imaging Sub-Study of a Randomized Control Trial

    Nicola Dalbeth1, Karen Billington2, Anthony Doyle1, Christopher Frampton3, Paul Tan1, Jordyn Allan1, Jill Drake4, Anne Horne5 and Lisa K. Stamp3, 1University of Auckland, Auckland, New Zealand, 2Auckland District Health Board, Auckland, New Zealand, 3University of Otago, Christchurch, New Zealand, 4University of Otago, Christchurch, Christchurch, New Zealand, 5Department of Medicine, University of Auckland, Auckland, New Zealand

    Background/Purpose: Bone erosion is a frequent complication of severe gout.  Computed tomography (CT) is considered the gold standard for measurement of bone erosion. CT studies…
  • Abstract Number: 60 • 2017 ACR/ARHP Annual Meeting

    Low and Moderate Intensity Exercise Suppresses Inflammatory Responses in an Acute Mouse Model of Gout and Suggests Therapeutic Efficacy

    Nicholas A. Young1, Kyle Jablonski2, Juhi Sharma1, Evelyn Thomas1, Brian Snoad1, Jeffrey Hampton3, Wael Jarjour1 and Naomi Schlesinger4, 1Department of Internal Medicine, Division of Immunology and Rheumatology, The Ohio State University Wexner Medical Center, Columbus, OH, 2The Ohio State University Wexner Medical Center, Columbus, OH, 3Immunology and Rheumatoloty, The Ohio State University Wexner Medical Center, Columbus, OH, 4Medicine, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ

    Background/Purpose: Little is known regarding the potential benefits of exercise on managing acute gout. Consequently, recent clinical practice guidelines released by the American College of…
  • Abstract Number: 99 • 2017 ACR/ARHP Annual Meeting

    A Pilot Study of the Use of a Validated Gout Script Concordance Test Assessment in an Interdisciplinary Musculoskeletal Education Program

    Bernadette C. Siaton1, Andrea Barker2 and Michael J. Battistone2, 1Rheumatology, University of Maryland School of Medicine, Baltimore, MD, 2Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT

    Background/Purpose: A validated script concordance assessment (SCT) for gout was created for use in the internal medicine residency program at the University of Maryland Medical…
  • Abstract Number: 117 • 2017 ACR/ARHP Annual Meeting

    Using Goutpro to Make Medical Trainees Gout Pros- a Single Blinded Randomized Control Study

    Linh Ngo1, Eric Miller2, Peter A. Valen3 and Alisa Duran4, 1Division of Rheumatology, University of Minnesota, Minneapolis, MN, 2Medicine, Hennepin County Medical Center, Minneapolis, MN, 3Rheumatology/ Dept of Medicine, University of Minnesota/Minneapolis VAMC, Minneapolis, MN, 4Department of Medicine, University of Minnesota, Minneapolis, MN

    Background/Purpose: Gout is the most common type of inflammatory arthritis in the U.S., affecting 4% of the population. Despite modern advancements and the availability of…
  • Abstract Number: 170 • 2017 ACR/ARHP Annual Meeting

    Genome-Wide Association Study of Clinically-Ascertained Gout and Subtypes Identifies Multiple Susceptibility Loci Including Transporter Genes

    Hirotaka Matsuo1, Akiyoshi Nakayama2, Hirofumi Nakaoka3, Ken Yamamoto4, Masayuki Sakiyama5, Amara Shaukat6, Yu Toyoda7, Yukinori Okada8, Yoichiro Kamatani9, Masahiro Nakatochi10, Takahiro Nakamura5, Tappei Takada7, Hiroshi Nakashima5, Seiko Shimizu5, Makoto Kawaguchi5, Asahi Hishida11, Kenji Wakai11, Blanka Stiburkova12, Karel Pavelka13, Lisa K. Stamp14, Nicola Dalbeth15, Tatsuo Hosoya16, Michiaki Kubo9, Hiroshi Ooyama17, Toru Shimizu18, Kimiyoshi Ichida19, Tony R. Merriman20 and Nariyoshi Shinomiya21, 1Department of Integrative Physiology and Bio-Nano Medicine, National Defense Medical College, Tokorozawa, Japan, 2Dept Integrative Physiol, National Defense Med College, Tokorozawa, Japan, 3National Inst Genet, Mishima, Japan, 4Department of Medical Chemistry, Kurume University School of Medicine, Kurume, Japan, 5National Defense Med College, Tokorozawa, Japan, 6Univ Otago, Dunedin, New Zealand, 7Univ Tokyo Hosp, Tokyo, Japan, 8Osaka University, Osaka, Japan, 9Center for Integrative Medical Sciences, RIKEN, Yokohama, Japan, 10Nagoya Univ Hosp, Nagoya, Japan, 11Nagoya Univ Grad Sch Med, Nagoya, Japan, 12Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University, Prague, Czech Republic, 13Institute of Rheumatology, Prague, Czech Republic, 14University of Otago, Christchurch, New Zealand, 15University of Auckland, Auckland, New Zealand, 16Jikei Univ Sch Med, Tokyo, Japan, 17Ryougoku East Gate Clin, Tokyo, Japan, 18Kyoto Industr Health Assoc, Kyoto, Japan, 19Tokyo Univ Pharmacy Life Sci, Tokyo, Japan, 20Biochemistry Dept, PO Box 56, University of Otago, Dunedin, New Zealand, 21National Defense Med College, Saitama, Japan

    Background/Purpose: We performed a genome-wide association study (GWAS) of gout and its subtypes to identify novel gout loci including those that are subtype-specific. Methods: Putative…
  • Abstract Number: 187 • 2017 ACR/ARHP Annual Meeting

    Improved Identification of Pseudogout in Electronic Medical Records By Adding Text String Searching to a Billing Code Algorithm

    Sara K. Tedeschi, Kazuki Yoshida and Daniel H. Solomon, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: Calcium pyrophosphate deposition disease (CPPD) has a spectrum of manifestations, of which pseudogout is the most acute inflammatory phenotype. To facilitate clinical research on…
  • Abstract Number: 200 • 2017 ACR/ARHP Annual Meeting

    Implementation and Evaluation of a Novel Nurse-Led Telemedicine Intervention for Dose Escalation of Urate-Lowering Therapy in Gout: A Clinical Practice Improvement Project

    Sen Hee Tay1,2, Bernadette Poh Lee Low3, Pamela Shi Hui Tan2, Zhi Wei Khong2, Siew Hwa Chong4, Amelia Santosa1,2, Anita Yee Nah Lim1,2 and Gim Gee Teng2,5, 1Division of Rheumatology, Department of Medicine, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 2Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore, Singapore, 3Division of Primary Care, Department of Care Integration and Alliance, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 4Clinical Nursing Unit, National University Hospital, National University Health System, Singapore, Singapore, Singapore, 5Division of Rheumatology, University Medicine Cluster, National University Health System, Singapore, Singapore, Singapore

    Background/Purpose:  Urate-lowering therapy (ULT) is the mainstay of gout treatment.  In our clinics, time to achieve target serum urate (SU) level during ULT titration was…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 96
  • Next Page »
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology